Two Sigma Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Two Sigma Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$776K	Buy	25,860 +9,500	+58%	+$315K	﹤0.01%	3440
2025 Q4	$535K	Sell	16,360 -6,099	-27%	-$197K	﹤0.01%	3266
2025 Q3	$778K	Buy	22,459 +800	+4%	+$25.6K	﹤0.01%	2741
2025 Q2	$606K	Sell	21,659 -27,502	-56%	-$737K	﹤0.01%	2500
2025 Q1	$1.23M	Buy	+49,161	New	+$1.24M	﹤0.01%	2050
2024 Q2	–	Sell	-22,714	Closed	-$731K	–	3144
2024 Q1	$731K	Buy	22,714 +12,588	+124%	+$468K	﹤0.01%	2140
2023 Q4	$412K	Sell	10,126 -2,074	-17%	-$76.3K	﹤0.01%	2558
2023 Q3	$422K	Sell	12,200 -600	-5%	-$23.4K	﹤0.01%	2348
2023 Q2	$520K	Buy	12,800 +900	+8%	+$36.7K	﹤0.01%	2313
2023 Q1	$460K	Buy	+11,900	New	+$489K	﹤0.01%	2242

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments's LKFT Position: Q1 2026 in Review

Two Sigma Investments increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 58% in Q1 2026, buying an estimated $315K and bringing the position to 25,860 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

Two Sigma Investments first reported a position in LKFT in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.23M in Q1 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Two Sigma Investments held 25,860 shares of Lakefront Biotherapeutics American Depositary Shares worth $776K as of Q1 2026.
Two Sigma Investments bought 9,500 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $315K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3440 holding.
Two Sigma Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and has held it in 10 quarters since.
Two Sigma Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.23M in Q1 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.